Cabeça e pescoço

A Phase III Randomized, Open-label, Multi-center, Global Study of MEDI4736 Alone or in Combination with Tremelimumab versus Standard of Care in the Treatment of First-line Recurrent or Metastatic Squamous Cell Head and Neck Cancer Patients

Contactos do Centro de Ensaio	Investigador Resonsável	Estado*	Nº EudraCT
Hospital de Santa Maria Av. Prof. Egas Moniz 1649-035 Lisboa - Portugal	Dra. Rita Sousa	Iniciar	2015-003589-10

* Recrutamento ou Iniciar